undefined undefined
NaN.000
NaN.00%
— 全球每年约有近 50 万名新诊断患者 — — 和黄医药的索凡替尼通过抑制血管生成和肿瘤相关巨噬细胞,与具有抗PD-1活性的恒瑞的卡瑞利珠单抗产生协同作用,促...
05-14 08:54
FTI Consulting (NYSE:FCN) late on Monday announced the appointment of Roy Huang as the Head of Asia & Caribbean, effective May 3. Based in Hong Kong, Huang will have executive responsibility for drivi...
05-07 15:18
Roy Huang Named Head of Asia & Caribbean; Will Also Lead Growth of the Busi...
05-07 09:00
Enterprise-class SecOps services from CyberProof leverage Google Chronicle Secu...
05-06 20:00
Fti Consulting (FCN) has issued an update. FTI Consulting presents an array of ...
04-27 05:13
FTI Consulting (NYSE:FCN) reported quarterly earnings of $2.23 per share which beat the analyst consensus estimate of $1.87 by 19.25 percent. This is a 66.42 percent increase over earnings of $1.34 per share from the
04-25 19:32
– Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantially All of the Co...
04-25 09:19
中国香港、上海和美国新泽西州:2024年3月22日,星期五:和黄医药(中国)有限公司(简称“和黄医药”或“HUTCHMED”)(纳斯达克/伦敦证交所:HCM;香...
03-22 08:48
①菲斯克高管发布声明表示,公司不对“市场传闻和猜测”发表评论; ②有知情人士透露,处于困境的菲斯克已聘请机构协助进行潜在的申请破产工作。
03-16 00:52